Drug Type T-lymphocyte cell therapy  | 
Synonyms Deep Il-12 Primed T cell, Deep IL-12 Primed T cells, TRQ 1201 + [1]  | 
Target  | 
Action stimulants, agonists  | 
Mechanism IL-12R stimulants(Interleukin-12 receptor stimulants), IL-15Rα agonists(Interleukin-15 receptor subunit alpha agonists)  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseDiscontinuedPreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Hematologic Neoplasms | Preclinical | United States   | - | |
| Solid tumor | Preclinical | United States   | - | 





